Protocol of a randomised controlled trial characterising the immune responses induced by varicella-zoster virus (VZV) vaccination in healthy Kenyan women: setting the stage for a potential VZV-based HIV vaccine

INTRODUCTION: A protective HIV vaccine would be expected to induce durable effector immune responses at the mucosa, restricting HIV infection at its portal of entry. We hypothesise that use of varicella-zoster virus (VZV) as an HIV delivery vector could generate sustained and robust tissue-based imm...

Descripción completa

Detalles Bibliográficos
Autores principales: Perciani, Catia T, Jaoko, Walter, Walmsley, Sharon, Farah, Bashir, Mahmud, Salaheddin M, Ostrowski, Mario, Anzala, Omu, Team, KAVI-ICR, MacDonald, Kelly S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2017
Materias:
HIV/AIDS
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5623463/
https://www.ncbi.nlm.nih.gov/pubmed/28939581
http://dx.doi.org/10.1136/bmjopen-2017-017391

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5623463/
https://www.ncbi.nlm.nih.gov/pubmed/28939581
http://dx.doi.org/10.1136/bmjopen-2017-017391

Ejemplares similares